9 recruiting. 9 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Recruiting 9 |
| Phase 1 | 2 | Recruiting 2 |
Follow Adrenocortical Hyperfunction: new trials by email Literature Review of Adrenocortical Hyperfunction trials Research Report on Adrenocortical Hyperfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS Metyrapone 250 mg Oral Tablets, Placebo - Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS) | Phase 2 | Recruiting | Mayo Clinic | 90 | 2026-10-01 | 2026-09-25 |
| Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS) Osilodrostat 1 MG - Mild Autonomous Cortisol Secretion, Autonomous Cortisol Secretion (ACS) | Phase 2 | Recruiting | Mayo Clinic | 15 | 2026-01-14 | 2026-02-11 |
| Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) clofutriben, Placebo - Type 2 Diabetes, Cortisol Excess | Phase 2 | Recruiting | Sparrow Pharmaceuticals | 1500 | 2025-11-29 | 2026-10-06 |
| Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome Desmopressin, Dexamethasone - Cushing Syndrome | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 140 | 2024-12-12 | 2026-08-31 |
| Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate [18F]CETO tracer, Dexamethasone oral, Adrenal vein sampling - Primary Aldosteronism | Phase 1 / Phase 2 | Recruiting | University Medical Center Groningen | 12 | 2024-11-06 | 2025-01-27 |
| Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism [68Ga]Ga-PentixaFor - Hyperaldosteronism, Hypercortisolism | Phase 2 | Recruiting | National Cancer Institute (NCI) | 80 | 2024-09-23 | 2026-10-22 |
| Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism Al18F-NOTA-Pentixafor PET/CT - Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma | Phase 1 / Phase 2 | Recruiting | Peking Union Medical College Hospital | 150 | 2023-12-30 | 2025-02-26 |
| Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome LCI699 - Cushing Syndrome | Phase 2 | Recruiting | RECORDATI GROUP | 12 | 2021-04-28 | 2026-03-27 |
| Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome DOTATATE PET-CT, F-DOPA PET CT, CT scan - ACTH, Cushing's Syndrome | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 80 | 2014-02-12 | 2026-10-02 |
Cushing Syndrome (7) · ACTH Syndrome, Ectopic (3) · Hyperaldosteronism (3) · Adrenal Hyperplasia, Congenital (2) · Adenoma (1) · Diabetes Mellitus, Type 2 (1) · Disease (1) · Pituitary Diseases (1)
Adrenal Gland Diseases (9) · Endocrine System Diseases (9) · Neoplasms (4) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Paraneoplastic Endocrine Syndromes (3) · Paraneoplastic Syndromes (3) · Adrenogenital Syndrome (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Disorders of Sex Development (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2)
Dexamethasone (2) · Osilodrostat (2) · ASP3662 (1) · Deamino Arginine Vasopressin (1) · Metyrapone (1) · fluorodopa F 18 (1) · gallium Ga 68 dotatate (1)
Mayo Clinic (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · National Cancer Institute (NCI) (1) · Peking Union Medical College Hospital (1) · RECORDATI GROUP (1) · Sparrow Pharmaceuticals (1) · University Medical Center Groningen (1)
United States (7) · Belgium (1) · Bulgaria (1) · China (1) · France (1) · Italy (1) · Netherlands (1) · Slovenia (1) · United Kingdom (1)
Lynnette K Nieman, M.D. (2) · Dr. M.N. Kerstens (1) · Irina Bancos, MD (1) · Irina Bancos, MD, MS (1) · Maria Liza Lindenberg, M.D. (1) · Recordati AG (1)
PMID 33859526, PMID 36074157, PMID 42535456
2018 (1), 2023 (1)